AutomedicationFrancoV1, Main, Exploration, bibRecord, 000032

Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada.

Identifieur interne : 000032 ( Main/Exploration ); précédent : 000031; suivant : 000033

Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada.

Auteurs : Dennis C. Wendt [Canada] ; Stéphanie Marsan [Canada] ; Daniel Parker [Canada] ; Karen E. Lizzy [États-Unis] ; Jessica Roper [Canada] ; Christopher Mushquash [Canada] ; Kamilla L. Venner [États-Unis] ; Alice Lam [Canada] ; Jennifer Swansburg [Canada] ; Nancy Worth [Canada] ; Nicholas Sorlagas [États-Unis] ; Tania Quach [Canada] ; Kristapore Manoukian [Canada] ; Payton Bernett [Canada] ; Sandra M. Radin [États-Unis]

Source :

Journal of substance abuse treatment [ 1873-6483 ] ; 2021.

RBID : pubmed:33097315

Descripteurs français

KwdFr :
- Antagonistes narcotiques (usage thérapeutique), Buprénorphine (usage thérapeutique), Canada (MeSH), Humains (MeSH), Santé mentale (MeSH), Traitement de substitution aux opiacés (MeSH), Troubles liés aux opiacés (rééducation et réadaptation), Types de pratiques des médecins (MeSH), Télémédecine (MeSH), États-Unis (MeSH).
MESH :
- rééducation et réadaptation : Troubles liés aux opiacés.
- usage thérapeutique : Antagonistes narcotiques, Buprénorphine.
- Canada, Humains, Santé mentale, Traitement de substitution aux opiacés, Types de pratiques des médecins, Télémédecine, États-Unis.
Wicri :
- geographic : Canada, États-Unis.

English descriptors

KwdEn :
- Buprenorphine (therapeutic use), COVID-19 (MeSH), Canada (MeSH), Humans (MeSH), Indigenous Peoples (MeSH), Mental Health (MeSH), Narcotic Antagonists (therapeutic use), Opiate Substitution Treatment (MeSH), Opioid-Related Disorders (rehabilitation), Practice Patterns, Physicians' (MeSH), Telemedicine (MeSH), United States (MeSH).
MESH :
- chemical , therapeutic use : Buprenorphine, Narcotic Antagonists.
- geographic : Canada, United States.
- rehabilitation : Opioid-Related Disorders.
- COVID-19, Humans, Indigenous Peoples, Mental Health, Opiate Substitution Treatment, Practice Patterns, Physicians', Telemedicine.

Abstract

This commentary focuses on how some Indigenous communities in the United States (U.S.) and Canada are addressing the opioid epidemic within the context of the COVID-19 pandemic, from the perspective of the co-authors as researchers, clinicians, and pharmacists working within or among Indigenous communities in three eastern Canadian provinces and two western U.S. states. The pandemic has likely exacerbated opioid use problems among Indigenous communities, especially for individuals with acute distress or comorbid mental illness, or who are in need of withdrawal management or residential services. In response to the pandemic, we discuss first how greater prescription flexibility has facilitated and even increased access to medications for opioid use disorder. Second, we describe how Indigenous-serving clinics have expanded telemedicine services, albeit not without some challenges. Third, we note challenges with restricted participation in traditional Indigenous healing practices that can be helpful for addiction recovery. Fourth, we mention providers' worries about the pandemic's impact on their patients' mental health and safety. We argue that certain treatment transformations may be helpful even after the pandemic is over, through enhancing access to community-grounded treatment, decreasing stigma, and promoting patient self-efficacy.

DOI: 10.1016/j.jsat.2020.108165
PubMed: 33097315
PubMed Central: PMC7546255

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000059
to stream Main, to step Curation: 000059

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada.</title>
<author><name sortKey="Wendt, Dennis C" sort="Wendt, Dennis C" uniqKey="Wendt D" first="Dennis C" last="Wendt">Dennis C. Wendt</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2, Canada. Electronic address: dennis.wendt@mcgill.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marsan, Stephanie" sort="Marsan, Stephanie" uniqKey="Marsan S" first="Stéphanie" last="Marsan">Stéphanie Marsan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Family and Emergency Medicine, Université de Montréal, Centre Hospitalier de l'Université de Montréal, 1051 Sanguinet St., Montreal, Quebec H2X 0C1, Canada. Electronic address: marsan.stephanie@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Family and Emergency Medicine, Université de Montréal, Centre Hospitalier de l'Université de Montréal, 1051 Sanguinet St., Montreal, Quebec H2X 0C1</wicri:regionArea>
<wicri:noRegion>Quebec H2X 0C1</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Parker, Daniel" sort="Parker, Daniel" uniqKey="Parker D" first="Daniel" last="Parker">Daniel Parker</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2, Canada. Electronic address: daniel.parker2@mail.mcgill.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lizzy, Karen E" sort="Lizzy, Karen E" uniqKey="Lizzy K" first="Karen E" last="Lizzy">Karen E. Lizzy</name>
<affiliation wicri:level="2"><nlm:affiliation>Cowlitz Tribal Health, 15455 65th Ave S, Tukwila, WA 98188, USA. Electronic address: klizzy@cowlitz.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cowlitz Tribal Health, 15455 65th Ave S, Tukwila, WA 98188</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roper, Jessica" sort="Roper, Jessica" uniqKey="Roper J" first="Jessica" last="Roper">Jessica Roper</name>
<affiliation wicri:level="1"><nlm:affiliation>Eskasoni Mental Health Services, 4555 Shore Rd., Eskasoni, Nova Scotia B1W 1K3, Canada. Electronic address: jessicaroper@eskasonihealth.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Eskasoni Mental Health Services, 4555 Shore Rd., Eskasoni, Nova Scotia B1W 1K3</wicri:regionArea>
<wicri:noRegion>Nova Scotia B1W 1K3</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mushquash, Christopher" sort="Mushquash, Christopher" uniqKey="Mushquash C" first="Christopher" last="Mushquash">Christopher Mushquash</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Psychology, Lakehead University, 955 Oliver Rd., Thunder Bay, Ontario P7B 5E1, Canada. Electronic address: chris.mushquash@lakeheadu.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Psychology, Lakehead University, 955 Oliver Rd., Thunder Bay, Ontario P7B 5E1</wicri:regionArea>
<wicri:noRegion>Ontario P7B 5E1</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Venner, Kamilla L" sort="Venner, Kamilla L" uniqKey="Venner K" first="Kamilla L" last="Venner">Kamilla L. Venner</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Psychology, Center on Alcoholism, Substance Abuse, and Addiction, University of New Mexico, 1 University of New Mexico, MSC03 2220, Albuquerque, NM 87131, USA. Electronic address: kamilla@unm.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychology, Center on Alcoholism, Substance Abuse, and Addiction, University of New Mexico, 1 University of New Mexico, MSC03 2220, Albuquerque, NM 87131</wicri:regionArea>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lam, Alice" sort="Lam, Alice" uniqKey="Lam A" first="Alice" last="Lam">Alice Lam</name>
<affiliation wicri:level="1"><nlm:affiliation>Canadian Research Initiative in Substance Misuse (CRISM) Quebec-Atlantic Node, Centre hospitalier de l'Université de Montréal, CRCHUM - Pavillon R, 900 St-Denis St., Montreal, Quebec H2X 0A9, Canada. Electronic address: alice1.crism@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Canadian Research Initiative in Substance Misuse (CRISM) Quebec-Atlantic Node, Centre hospitalier de l'Université de Montréal, CRCHUM - Pavillon R, 900 St-Denis St., Montreal, Quebec H2X 0A9</wicri:regionArea>
<wicri:noRegion>Quebec H2X 0A9</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Swansburg, Jennifer" sort="Swansburg, Jennifer" uniqKey="Swansburg J" first="Jennifer" last="Swansburg">Jennifer Swansburg</name>
<affiliation wicri:level="1"><nlm:affiliation>Canadian Research Initiative in Substance Misuse (CRISM) Quebec-Atlantic Node, Department of Psychology, Dalhousie University, 1355 Oxford St., P.O. Box 15000, Halifax, Nova Scotia B3H 4R2, Canada. Electronic address: jennifer.crism@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Canadian Research Initiative in Substance Misuse (CRISM) Quebec-Atlantic Node, Department of Psychology, Dalhousie University, 1355 Oxford St., P.O. Box 15000, Halifax, Nova Scotia B3H 4R2</wicri:regionArea>
<wicri:noRegion>Nova Scotia B3H 4R2</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Worth, Nancy" sort="Worth, Nancy" uniqKey="Worth N" first="Nancy" last="Worth">Nancy Worth</name>
<affiliation wicri:level="1"><nlm:affiliation>Kahnawake Shakotiia'takehnhas Community Services (KSCS), P.O. Box 1440, Kahnawake, Quebec J0L 1B0, Canada. Electronic address: nancyw@kscskahnawake.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Kahnawake Shakotiia'takehnhas Community Services (KSCS), P.O. Box 1440, Kahnawake, Quebec J0L 1B0</wicri:regionArea>
<wicri:noRegion>Quebec J0L 1B0</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sorlagas, Nicholas" sort="Sorlagas, Nicholas" uniqKey="Sorlagas N" first="Nicholas" last="Sorlagas">Nicholas Sorlagas</name>
<affiliation wicri:level="4"><nlm:affiliation>Alcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th St., Seattle, WA 98105, USA. Electronic address: nicos@uw.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Alcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th St., Seattle, WA 98105</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
<settlement type="city">Seattle</settlement>
</placeName>
<orgName type="university">Université de Washington</orgName>
</affiliation>
</author>
<author><name sortKey="Quach, Tania" sort="Quach, Tania" uniqKey="Quach T" first="Tania" last="Quach">Tania Quach</name>
<affiliation wicri:level="1"><nlm:affiliation>Kateri Memorial Hospital Centre (KMHC), 10 River Rd., Kahnawake, Quebec J0L 1B0, Canada. Electronic address: myvanmyvan@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Kateri Memorial Hospital Centre (KMHC), 10 River Rd., Kahnawake, Quebec J0L 1B0</wicri:regionArea>
<wicri:noRegion>Quebec J0L 1B0</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Manoukian, Kristapore" sort="Manoukian, Kristapore" uniqKey="Manoukian K" first="Kristapore" last="Manoukian">Kristapore Manoukian</name>
<affiliation wicri:level="1"><nlm:affiliation>Proxim Pharmacie Kristapore Manoukian, Inc., P.O. Box 2231, Kahnawake, Quebec J0L 1B0, Canada. Electronic address: kristapore@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Proxim Pharmacie Kristapore Manoukian, Inc., P.O. Box 2231, Kahnawake, Quebec J0L 1B0</wicri:regionArea>
<wicri:noRegion>Quebec J0L 1B0</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bernett, Payton" sort="Bernett, Payton" uniqKey="Bernett P" first="Payton" last="Bernett">Payton Bernett</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2, Canada. Electronic address: payton.bernett@mail.mcgill.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Radin, Sandra M" sort="Radin, Sandra M" uniqKey="Radin S" first="Sandra M" last="Radin">Sandra M. Radin</name>
<affiliation wicri:level="4"><nlm:affiliation>Alcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th St., Seattle, WA 98105, USA. Electronic address: sradin@uw.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Alcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th St., Seattle, WA 98105</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
<settlement type="city">Seattle</settlement>
</placeName>
<orgName type="university">Université de Washington</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33097315</idno>
<idno type="pmid">33097315</idno>
<idno type="doi">10.1016/j.jsat.2020.108165</idno>
<idno type="pmc">PMC7546255</idno>
<idno type="wicri:Area/Main/Corpus">000059</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000059</idno>
<idno type="wicri:Area/Main/Curation">000059</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000059</idno>
<idno type="wicri:Area/Main/Exploration">000059</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada.</title>
<author><name sortKey="Wendt, Dennis C" sort="Wendt, Dennis C" uniqKey="Wendt D" first="Dennis C" last="Wendt">Dennis C. Wendt</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2, Canada. Electronic address: dennis.wendt@mcgill.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Marsan, Stephanie" sort="Marsan, Stephanie" uniqKey="Marsan S" first="Stéphanie" last="Marsan">Stéphanie Marsan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Family and Emergency Medicine, Université de Montréal, Centre Hospitalier de l'Université de Montréal, 1051 Sanguinet St., Montreal, Quebec H2X 0C1, Canada. Electronic address: marsan.stephanie@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Family and Emergency Medicine, Université de Montréal, Centre Hospitalier de l'Université de Montréal, 1051 Sanguinet St., Montreal, Quebec H2X 0C1</wicri:regionArea>
<wicri:noRegion>Quebec H2X 0C1</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Parker, Daniel" sort="Parker, Daniel" uniqKey="Parker D" first="Daniel" last="Parker">Daniel Parker</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2, Canada. Electronic address: daniel.parker2@mail.mcgill.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lizzy, Karen E" sort="Lizzy, Karen E" uniqKey="Lizzy K" first="Karen E" last="Lizzy">Karen E. Lizzy</name>
<affiliation wicri:level="2"><nlm:affiliation>Cowlitz Tribal Health, 15455 65th Ave S, Tukwila, WA 98188, USA. Electronic address: klizzy@cowlitz.org.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cowlitz Tribal Health, 15455 65th Ave S, Tukwila, WA 98188</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roper, Jessica" sort="Roper, Jessica" uniqKey="Roper J" first="Jessica" last="Roper">Jessica Roper</name>
<affiliation wicri:level="1"><nlm:affiliation>Eskasoni Mental Health Services, 4555 Shore Rd., Eskasoni, Nova Scotia B1W 1K3, Canada. Electronic address: jessicaroper@eskasonihealth.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Eskasoni Mental Health Services, 4555 Shore Rd., Eskasoni, Nova Scotia B1W 1K3</wicri:regionArea>
<wicri:noRegion>Nova Scotia B1W 1K3</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mushquash, Christopher" sort="Mushquash, Christopher" uniqKey="Mushquash C" first="Christopher" last="Mushquash">Christopher Mushquash</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Psychology, Lakehead University, 955 Oliver Rd., Thunder Bay, Ontario P7B 5E1, Canada. Electronic address: chris.mushquash@lakeheadu.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Psychology, Lakehead University, 955 Oliver Rd., Thunder Bay, Ontario P7B 5E1</wicri:regionArea>
<wicri:noRegion>Ontario P7B 5E1</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Venner, Kamilla L" sort="Venner, Kamilla L" uniqKey="Venner K" first="Kamilla L" last="Venner">Kamilla L. Venner</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Psychology, Center on Alcoholism, Substance Abuse, and Addiction, University of New Mexico, 1 University of New Mexico, MSC03 2220, Albuquerque, NM 87131, USA. Electronic address: kamilla@unm.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychology, Center on Alcoholism, Substance Abuse, and Addiction, University of New Mexico, 1 University of New Mexico, MSC03 2220, Albuquerque, NM 87131</wicri:regionArea>
<placeName><region type="state">Nouveau-Mexique</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lam, Alice" sort="Lam, Alice" uniqKey="Lam A" first="Alice" last="Lam">Alice Lam</name>
<affiliation wicri:level="1"><nlm:affiliation>Canadian Research Initiative in Substance Misuse (CRISM) Quebec-Atlantic Node, Centre hospitalier de l'Université de Montréal, CRCHUM - Pavillon R, 900 St-Denis St., Montreal, Quebec H2X 0A9, Canada. Electronic address: alice1.crism@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Canadian Research Initiative in Substance Misuse (CRISM) Quebec-Atlantic Node, Centre hospitalier de l'Université de Montréal, CRCHUM - Pavillon R, 900 St-Denis St., Montreal, Quebec H2X 0A9</wicri:regionArea>
<wicri:noRegion>Quebec H2X 0A9</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Swansburg, Jennifer" sort="Swansburg, Jennifer" uniqKey="Swansburg J" first="Jennifer" last="Swansburg">Jennifer Swansburg</name>
<affiliation wicri:level="1"><nlm:affiliation>Canadian Research Initiative in Substance Misuse (CRISM) Quebec-Atlantic Node, Department of Psychology, Dalhousie University, 1355 Oxford St., P.O. Box 15000, Halifax, Nova Scotia B3H 4R2, Canada. Electronic address: jennifer.crism@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Canadian Research Initiative in Substance Misuse (CRISM) Quebec-Atlantic Node, Department of Psychology, Dalhousie University, 1355 Oxford St., P.O. Box 15000, Halifax, Nova Scotia B3H 4R2</wicri:regionArea>
<wicri:noRegion>Nova Scotia B3H 4R2</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Worth, Nancy" sort="Worth, Nancy" uniqKey="Worth N" first="Nancy" last="Worth">Nancy Worth</name>
<affiliation wicri:level="1"><nlm:affiliation>Kahnawake Shakotiia'takehnhas Community Services (KSCS), P.O. Box 1440, Kahnawake, Quebec J0L 1B0, Canada. Electronic address: nancyw@kscskahnawake.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Kahnawake Shakotiia'takehnhas Community Services (KSCS), P.O. Box 1440, Kahnawake, Quebec J0L 1B0</wicri:regionArea>
<wicri:noRegion>Quebec J0L 1B0</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sorlagas, Nicholas" sort="Sorlagas, Nicholas" uniqKey="Sorlagas N" first="Nicholas" last="Sorlagas">Nicholas Sorlagas</name>
<affiliation wicri:level="4"><nlm:affiliation>Alcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th St., Seattle, WA 98105, USA. Electronic address: nicos@uw.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Alcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th St., Seattle, WA 98105</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
<settlement type="city">Seattle</settlement>
</placeName>
<orgName type="university">Université de Washington</orgName>
</affiliation>
</author>
<author><name sortKey="Quach, Tania" sort="Quach, Tania" uniqKey="Quach T" first="Tania" last="Quach">Tania Quach</name>
<affiliation wicri:level="1"><nlm:affiliation>Kateri Memorial Hospital Centre (KMHC), 10 River Rd., Kahnawake, Quebec J0L 1B0, Canada. Electronic address: myvanmyvan@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Kateri Memorial Hospital Centre (KMHC), 10 River Rd., Kahnawake, Quebec J0L 1B0</wicri:regionArea>
<wicri:noRegion>Quebec J0L 1B0</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Manoukian, Kristapore" sort="Manoukian, Kristapore" uniqKey="Manoukian K" first="Kristapore" last="Manoukian">Kristapore Manoukian</name>
<affiliation wicri:level="1"><nlm:affiliation>Proxim Pharmacie Kristapore Manoukian, Inc., P.O. Box 2231, Kahnawake, Quebec J0L 1B0, Canada. Electronic address: kristapore@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Proxim Pharmacie Kristapore Manoukian, Inc., P.O. Box 2231, Kahnawake, Quebec J0L 1B0</wicri:regionArea>
<wicri:noRegion>Quebec J0L 1B0</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bernett, Payton" sort="Bernett, Payton" uniqKey="Bernett P" first="Payton" last="Bernett">Payton Bernett</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2, Canada. Electronic address: payton.bernett@mail.mcgill.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Radin, Sandra M" sort="Radin, Sandra M" uniqKey="Radin S" first="Sandra M" last="Radin">Sandra M. Radin</name>
<affiliation wicri:level="4"><nlm:affiliation>Alcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th St., Seattle, WA 98105, USA. Electronic address: sradin@uw.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Alcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th St., Seattle, WA 98105</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
<settlement type="city">Seattle</settlement>
</placeName>
<orgName type="university">Université de Washington</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of substance abuse treatment</title>
<idno type="eISSN">1873-6483</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Buprenorphine (therapeutic use)</term>
<term>COVID-19 (MeSH)</term>
<term>Canada (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Indigenous Peoples (MeSH)</term>
<term>Mental Health (MeSH)</term>
<term>Narcotic Antagonists (therapeutic use)</term>
<term>Opiate Substitution Treatment (MeSH)</term>
<term>Opioid-Related Disorders (rehabilitation)</term>
<term>Practice Patterns, Physicians' (MeSH)</term>
<term>Telemedicine (MeSH)</term>
<term>United States (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antagonistes narcotiques (usage thérapeutique)</term>
<term>Buprénorphine (usage thérapeutique)</term>
<term>Canada (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Santé mentale (MeSH)</term>
<term>Traitement de substitution aux opiacés (MeSH)</term>
<term>Troubles liés aux opiacés (rééducation et réadaptation)</term>
<term>Types de pratiques des médecins (MeSH)</term>
<term>Télémédecine (MeSH)</term>
<term>États-Unis (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Buprenorphine</term>
<term>Narcotic Antagonists</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Canada</term>
<term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Opioid-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Troubles liés aux opiacés</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antagonistes narcotiques</term>
<term>Buprénorphine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Humans</term>
<term>Indigenous Peoples</term>
<term>Mental Health</term>
<term>Opiate Substitution Treatment</term>
<term>Practice Patterns, Physicians'</term>
<term>Telemedicine</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Canada</term>
<term>Humains</term>
<term>Santé mentale</term>
<term>Traitement de substitution aux opiacés</term>
<term>Types de pratiques des médecins</term>
<term>Télémédecine</term>
<term>États-Unis</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term>
<term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This commentary focuses on how some Indigenous communities in the United States (U.S.) and Canada are addressing the opioid epidemic within the context of the COVID-19 pandemic, from the perspective of the co-authors as researchers, clinicians, and pharmacists working within or among Indigenous communities in three eastern Canadian provinces and two western U.S. states. The pandemic has likely exacerbated opioid use problems among Indigenous communities, especially for individuals with acute distress or comorbid mental illness, or who are in need of withdrawal management or residential services. In response to the pandemic, we discuss first how greater prescription flexibility has facilitated and even increased access to medications for opioid use disorder. Second, we describe how Indigenous-serving clinics have expanded telemedicine services, albeit not without some challenges. Third, we note challenges with restricted participation in traditional Indigenous healing practices that can be helpful for addiction recovery. Fourth, we mention providers' worries about the pandemic's impact on their patients' mental health and safety. We argue that certain treatment transformations may be helpful even after the pandemic is over, through enhancing access to community-grounded treatment, decreasing stigma, and promoting patient self-efficacy.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33097315</PMID>
<DateCompleted><Year>2021</Year>
<Month>01</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6483</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>121</Volume>
<PubDate><Year>2021</Year>
<Month>02</Month>
</PubDate>
</JournalIssue>
<Title>Journal of substance abuse treatment</Title>
<ISOAbbreviation>J Subst Abuse Treat</ISOAbbreviation>
</Journal>
<ArticleTitle>Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada.</ArticleTitle>
<Pagination><MedlinePgn>108165</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0740-5472(20)30422-0</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jsat.2020.108165</ELocationID>
<Abstract><AbstractText>This commentary focuses on how some Indigenous communities in the United States (U.S.) and Canada are addressing the opioid epidemic within the context of the COVID-19 pandemic, from the perspective of the co-authors as researchers, clinicians, and pharmacists working within or among Indigenous communities in three eastern Canadian provinces and two western U.S. states. The pandemic has likely exacerbated opioid use problems among Indigenous communities, especially for individuals with acute distress or comorbid mental illness, or who are in need of withdrawal management or residential services. In response to the pandemic, we discuss first how greater prescription flexibility has facilitated and even increased access to medications for opioid use disorder. Second, we describe how Indigenous-serving clinics have expanded telemedicine services, albeit not without some challenges. Third, we note challenges with restricted participation in traditional Indigenous healing practices that can be helpful for addiction recovery. Fourth, we mention providers' worries about the pandemic's impact on their patients' mental health and safety. We argue that certain treatment transformations may be helpful even after the pandemic is over, through enhancing access to community-grounded treatment, decreasing stigma, and promoting patient self-efficacy.</AbstractText>
<CopyrightInformation>Copyright © 2020 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wendt</LastName>
<ForeName>Dennis C</ForeName>
<Initials>DC</Initials>
<AffiliationInfo><Affiliation>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2, Canada. Electronic address: dennis.wendt@mcgill.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Marsan</LastName>
<ForeName>Stéphanie</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Family and Emergency Medicine, Université de Montréal, Centre Hospitalier de l'Université de Montréal, 1051 Sanguinet St., Montreal, Quebec H2X 0C1, Canada. Electronic address: marsan.stephanie@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Parker</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2, Canada. Electronic address: daniel.parker2@mail.mcgill.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lizzy</LastName>
<ForeName>Karen E</ForeName>
<Initials>KE</Initials>
<AffiliationInfo><Affiliation>Cowlitz Tribal Health, 15455 65th Ave S, Tukwila, WA 98188, USA. Electronic address: klizzy@cowlitz.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Roper</LastName>
<ForeName>Jessica</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Eskasoni Mental Health Services, 4555 Shore Rd., Eskasoni, Nova Scotia B1W 1K3, Canada. Electronic address: jessicaroper@eskasonihealth.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mushquash</LastName>
<ForeName>Christopher</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Psychology, Lakehead University, 955 Oliver Rd., Thunder Bay, Ontario P7B 5E1, Canada. Electronic address: chris.mushquash@lakeheadu.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Venner</LastName>
<ForeName>Kamilla L</ForeName>
<Initials>KL</Initials>
<AffiliationInfo><Affiliation>Department of Psychology, Center on Alcoholism, Substance Abuse, and Addiction, University of New Mexico, 1 University of New Mexico, MSC03 2220, Albuquerque, NM 87131, USA. Electronic address: kamilla@unm.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lam</LastName>
<ForeName>Alice</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Canadian Research Initiative in Substance Misuse (CRISM) Quebec-Atlantic Node, Centre hospitalier de l'Université de Montréal, CRCHUM - Pavillon R, 900 St-Denis St., Montreal, Quebec H2X 0A9, Canada. Electronic address: alice1.crism@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Swansburg</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Canadian Research Initiative in Substance Misuse (CRISM) Quebec-Atlantic Node, Department of Psychology, Dalhousie University, 1355 Oxford St., P.O. Box 15000, Halifax, Nova Scotia B3H 4R2, Canada. Electronic address: jennifer.crism@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Worth</LastName>
<ForeName>Nancy</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Kahnawake Shakotiia'takehnhas Community Services (KSCS), P.O. Box 1440, Kahnawake, Quebec J0L 1B0, Canada. Electronic address: nancyw@kscskahnawake.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sorlagas</LastName>
<ForeName>Nicholas</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Alcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th St., Seattle, WA 98105, USA. Electronic address: nicos@uw.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Quach</LastName>
<ForeName>Tania</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Kateri Memorial Hospital Centre (KMHC), 10 River Rd., Kahnawake, Quebec J0L 1B0, Canada. Electronic address: myvanmyvan@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Manoukian</LastName>
<ForeName>Kristapore</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Proxim Pharmacie Kristapore Manoukian, Inc., P.O. Box 2231, Kahnawake, Quebec J0L 1B0, Canada. Electronic address: kristapore@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bernett</LastName>
<ForeName>Payton</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Educational and Counselling Psychology, McGill University, 3700 McTavish St., Room 614, Montreal, Quebec H3A 1Y2, Canada. Electronic address: payton.bernett@mail.mcgill.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Radin</LastName>
<ForeName>Sandra M</ForeName>
<Initials>SM</Initials>
<AffiliationInfo><Affiliation>Alcohol and Drug Abuse Institute, University of Washington, 1107 NE 45th St., Seattle, WA 98105, USA. Electronic address: sradin@uw.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>10</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Subst Abuse Treat</MedlineTA>
<NlmUniqueID>8500909</NlmUniqueID>
<ISSNLinking>0740-5472</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009292">Narcotic Antagonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>40D3SCR4GZ</RegistryNumber>
<NameOfSubstance UI="D002047">Buprenorphine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002047" MajorTopicYN="N">Buprenorphine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000081034" MajorTopicYN="Y">Indigenous Peoples</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009292" MajorTopicYN="N">Narcotic Antagonists</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058850" MajorTopicYN="Y">Opiate Substitution Treatment</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009293" MajorTopicYN="N">Opioid-Related Disorders</DescriptorName>
<QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010818" MajorTopicYN="Y">Practice Patterns, Physicians'</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">Indigenous Peoples</Keyword>
<Keyword MajorTopicYN="Y">Medication for opioid use disorder</Keyword>
<Keyword MajorTopicYN="Y">Opioid use disorder</Keyword>
<Keyword MajorTopicYN="Y">Opioid-agonist treatment</Keyword>
<Keyword MajorTopicYN="Y">Telemedicine</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>06</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>09</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>10</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>10</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>1</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>10</Month>
<Day>24</Day>
<Hour>5</Hour>
<Minute>27</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33097315</ArticleId>
<ArticleId IdType="pii">S0740-5472(20)30422-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.jsat.2020.108165</ArticleId>
<ArticleId IdType="pmc">PMC7546255</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Int J Drug Policy. 2019 Dec;74:257-265</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30765118</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Subst Abuse Treat Prev Policy. 2014 Sep 01;9:34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25179797</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Can Fam Physician. 2015 Feb;61(2):160-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25821874</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Promot Chronic Dis Prev Can. 2018 Jun;38(6):224-233</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29911818</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Addict Behav. 2018 Nov;86:111-117</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29914717</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Jul 7;173(1):57-58</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32240283</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Netw Open. 2020 Apr 1;3(4):e203711</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32320038</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Rural Remote Health. 2015;15:3019</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25651434</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Can J Public Health. 2018 Apr;109(2):219-222</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29981036</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Can Fam Physician. 2017 Feb;63(2):137-145</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28209683</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Equity Health. 2019 Nov 14;18(1):174</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31727076</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2020 Jul 7;173(1):59-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32240291</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychiatr Serv. 2017 Nov 1;68(11):1136-1143</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28712352</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Psychiatry. 2020 Jul 15;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32667648</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Soc Sci Med. 2019 Aug;234:112384</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31254965</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychiatr Serv. 2014 Feb 1;65(2):158-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24247147</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychiatr Serv. 2014 Feb 1;65(2):146-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24248468</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Psychoactive Drugs. 2011 Oct-Dec;43(4):282-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22400458</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Can J Public Health. 2015 Jun 24;106(6):e382-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26680429</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Behav Health Serv Res. 2013 Jul;40(3):367-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23702611</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
<li>États-Unis</li>
</country>
<region><li>Nouveau-Mexique</li>
<li>Québec</li>
<li>Washington (État)</li>
</region>
<settlement><li>Montréal</li>
<li>Seattle</li>
</settlement>
<orgName><li>Université McGill</li>
<li>Université de Washington</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Québec"><name sortKey="Wendt, Dennis C" sort="Wendt, Dennis C" uniqKey="Wendt D" first="Dennis C" last="Wendt">Dennis C. Wendt</name>
</region>
<name sortKey="Bernett, Payton" sort="Bernett, Payton" uniqKey="Bernett P" first="Payton" last="Bernett">Payton Bernett</name>
<name sortKey="Lam, Alice" sort="Lam, Alice" uniqKey="Lam A" first="Alice" last="Lam">Alice Lam</name>
<name sortKey="Manoukian, Kristapore" sort="Manoukian, Kristapore" uniqKey="Manoukian K" first="Kristapore" last="Manoukian">Kristapore Manoukian</name>
<name sortKey="Marsan, Stephanie" sort="Marsan, Stephanie" uniqKey="Marsan S" first="Stéphanie" last="Marsan">Stéphanie Marsan</name>
<name sortKey="Mushquash, Christopher" sort="Mushquash, Christopher" uniqKey="Mushquash C" first="Christopher" last="Mushquash">Christopher Mushquash</name>
<name sortKey="Parker, Daniel" sort="Parker, Daniel" uniqKey="Parker D" first="Daniel" last="Parker">Daniel Parker</name>
<name sortKey="Quach, Tania" sort="Quach, Tania" uniqKey="Quach T" first="Tania" last="Quach">Tania Quach</name>
<name sortKey="Roper, Jessica" sort="Roper, Jessica" uniqKey="Roper J" first="Jessica" last="Roper">Jessica Roper</name>
<name sortKey="Swansburg, Jennifer" sort="Swansburg, Jennifer" uniqKey="Swansburg J" first="Jennifer" last="Swansburg">Jennifer Swansburg</name>
<name sortKey="Worth, Nancy" sort="Worth, Nancy" uniqKey="Worth N" first="Nancy" last="Worth">Nancy Worth</name>
</country>
<country name="États-Unis"><region name="Washington (État)"><name sortKey="Lizzy, Karen E" sort="Lizzy, Karen E" uniqKey="Lizzy K" first="Karen E" last="Lizzy">Karen E. Lizzy</name>
</region>
<name sortKey="Radin, Sandra M" sort="Radin, Sandra M" uniqKey="Radin S" first="Sandra M" last="Radin">Sandra M. Radin</name>
<name sortKey="Sorlagas, Nicholas" sort="Sorlagas, Nicholas" uniqKey="Sorlagas N" first="Nicholas" last="Sorlagas">Nicholas Sorlagas</name>
<name sortKey="Venner, Kamilla L" sort="Venner, Kamilla L" uniqKey="Venner K" first="Kamilla L" last="Venner">Kamilla L. Venner</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000032 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000032 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    AutomedicationFrancoV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33097315
   |texte=   Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33097315" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AutomedicationFrancoV1

This area was generated with Dilib version V0.6.38.
Data generation: Mon Mar 15 15:24:36 2021. Site generation: Mon Mar 15 15:32:03 2021

	Serveur d'exploration sur l'automédication dans le monde francophone
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur l'automédication dans le monde francophone

Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada.

Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki